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BACKGROUND: Attention-deﬁcit/hyperactivity disorder (ADHD) symptoms are most commonly treated with stimu-
lant medication such as methylphenidate (MPH); however, approximately 25% of patients show little or no symp-
tomatic response. We examined the extent to which initial changes in brain functional connectivity (FC) associated
with the ﬁrst MPH dose in boys newly diagnosed with ADHD predict MPH-associated changes in ADHD
inattentiveness and hyperactivity symptoms at 3 months.
METHODS: Brain FC was estimated using steady-state visual evoked potential partial coherence before and 90
minutes after the administration of the ﬁrst MPH dose to 40 stimulant drug–naïve boys newly diagnosed with
ADHD while they performed the AX version of the continuous performance task. The change in parent-rated
inattention and hyperactivity scores over the ﬁrst 3 months of MPH medication was correlated with the initial 90-
minute MPH-mediated FC changes.
RESULTS: Hyperactivity improvements at 3 months were associated with ﬁrst-dose MPH–mediated FC reductions
restricted to frontal-prefrontal sites following the appearance of the “A” and at frontal and right temporal sites
during the appearance of the “X.” Corresponding 3-month inattention score improvement was associated with
initial MPH–mediated FC reductions restricted to occipitoparietal sites following the appearance of the “A.”
CONCLUSIONS: These ﬁndings are discussed in the context of MPH effects on the default mode network and the
possible role of the default mode network in MPH-mediated improvements in inattention and hyperactivity symptom
scores.
Keywords: ADHD symptoms, Brain functional connectivity, Methylphenidate, Occipital cortex, Prefrontal cortex,
Steady-state visually evoked potential
http://dx.doi.org/10.1016/j.biopsych.2017.03.022Attention-deﬁcit/hyperactivity disorder (ADHD), a disorder that
is characterized by symptoms of inattention and/or impulsivity
and hyperactivity, is one of the most commonly diagnosed
pediatric neuropsychiatric disorders, affecting an estimated
3% to 6% of children (1). An important component of various
theories concerning ADHD has been the role of the catechol-
amines norepinephrine (NE) and especially dopamine (DA). It
has been suggested that ADHD is a consequence of reduced
DA activity as a result of either increased DA synaptic reuptake
or reduced postsynaptic sensitivity at frontostriatocerebellar
networks (2,3). Methylphenidate (MPH) is one of the most
commonly prescribed stimulants for the management of ADHD
symptoms; it acts to increase DA and NE availability by
inhibiting reuptake of these catecholamines (4). While MPH
and other stimulants are broadly effective in the management
of ADHD symptoms, it is estimated that approximately 25% of
patients with ADHD receiving stimulant medication show little
or no symptomatic improvement (5). The ability to identifyª 2017 Society of B
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N: 0006-3223 Biologipatients with ADHD likely to respond favorably to stimulant
medication prospectively is thus important on two grounds.
First, if stimulant medication nonresponders can be identiﬁed,
ineffective medication and related side effects can be avoided.
Second, an understanding of the factors contributing to stim-
ulant medication response would shed additional light on the
neurobiological basis of ADHD.
While the cognitive enhancing effect of MPH has generally
been considered a consequence of DA-related increases in
prefrontal activity (6,7), more recently, another perspective on
the brain function abnormalities underlying ADHD and the role
of stimulants in symptom management has emerged. This
perspective views ADHD as a disorder of functional connec-
tivity (FC) rather than an abnormality restricted to speciﬁc
cortical regions (8). The main development making this reap-
praisal possible was the recognition of a speciﬁc cortical
network known as the default mode network (DMN) (9). The
DMN is most active when awake subjects are engaged iniological Psychiatry. This is an open access article under the
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Psychiatrystimulus-independent cognition, such as daydreaming, and
exhibits reduced activity when task-positive networks become
active during a cognitive task (9,10).
A reduced negative correlation between the DMN and task
active networks has been reported in ADHD suggesting that
the inattentiveness observed in this condition is a conse-
quence of inadequate suppression of the DMN and
increased intrusion of thoughts unrelated to the task (11,12).
A number of authors suggest that ADHD could be consid-
ered a default network disorder (13–17). The suggested role
of the DMN in ADHD symptomatology is also consistent with
ﬁndings concerning the effects of stimulant medication on
DMN activity. While undertaking a cognitive task, subjects
with ADHD showed greater suppression of the DMN while
on stimulant medication compared with the off-medication
state (18–20).
Given the centrality of the role of DA in theories of ADHD,
a number of studies have examined the relationship between
the acute effects of DA on brain function in ADHD and the
long-term clinical response to stimulant medication. Bush (21)
examined the effect of MPH in a group of adults diagnosed
with ADHD and reported that 6-week clinical improvements
were associated with increased activity in task-positive net-
works and greater inhibition of the DMN. Analogous ﬁndings
were reported by Schulz et al. (22), noting that the major
MPH-related changes in brain activity associated with ADHD
symptom improvements over a 6- to 8-week period were
reductions at bilateral primary motor cortex, left supplemen-
tary motor cortex, and bilateral posterior cingulate cortex.
While the authors attributed the reductions in motor cortex
activity to the improvements in impulse control, the posterior
cingulate reductions were interpreted as reﬂecting improved
suppression of the DMN. However, while the relationship
between MPH and the resultant changes in brain activity in
ADHD appears robust, the relationship between changes in
brain activity and improvements in ADHD symptoms is not
always apparent (23).
We have previously used a steady-state visually evoked
potential (SSVEP)–based methodology to examine cognitive
task-related changes in brain electrical activity in ADHD (24) as
well as task-related changes in brain FC in ADHD (25). In an
earlier study (26), we examined FC changes in response to an
MPH dose in a stimulant drug–naïve group of boys newly
diagnosed with ADHD while they performed the AX version of
the continuous performance task (CPT-AX). We found that
MPH robustly reduced the task-related transient FC increase
observed in the ADHD group. Furthermore, we observed a
signiﬁcant positive correlation between MPH-induced changes
in reaction time (RT) during the CPT-AX and the MPH-induced
changes in FC so that larger RT reductions were associated
with larger FC reductions. Given that RT deﬁcits are one of the
most common observations in ADHD (27), we hypothesized a
relationship between the initial changes in FC observed as a
result of a single MPH dose and the change in clinical symp-
tom score observed over a longer and more clinically relevant
interval. In the present study, we speciﬁcally hypothesized that
the 3-month improvement in ADHD symptom scores would be
associated with the initial FC reduction observed following the
ﬁrst administration of MPH to a group of boys newly diagnosed
with ADHD.680 Biological Psychiatry November 1, 2017; 82:679–686 www.sobp.oMETHODS AND MATERIALS
Participants
The participants comprised 40 right-handed, stimulant drug–
naïve boys (mean age 121 months [SD 21 months], mean IQ
101.3 [SD 14.4]) newly clinically diagnosed with ADHD
according to DSM-IV criteria (28). All participants were pre-
scribed MPH as the sole pharmaceutical treatment for ADHD.
Parents gave their written consent after receiving a complete
detailed description of the study. The study was approved by
the Human Research Ethics Committees of Swinburne
University and the Royal Children’s Hospital.ADHD Symptom Score Assessment
Before the electroencephalogram (EEG) recording session and
3 months after the recording session and the start of MPH
treatment, parents completed a questionnaire based on DSM-
IV criteria for ADHD (28) to rate the severity of inattention and
hyperactivity symptoms. The maximum symptom score for
either inattention or hyperactivity symptoms is 27 based on a
4-point scale (0, 1, 2, 3) for nine questions in each category. A
symptom improvement score (SIS) was calculated separately
for inattention (I-SIS) and hyperactivity (H-SIS) symptoms
based on the following proportional difference formula: SIS =
(initial symptom score 2 ﬁnal symptom score)/(initial symptom
score).Procedures
Participants ﬁrst performed a low-demand reference task
followed by the CPT-AX. Both the reference task and the CPT-
AX were undertaken twice: immediately before and then 90
minutes after the participants were administered their ﬁrst
MPH dose (0.3 mg/kg participant weight).
In the reference task, participants viewed a repeated pre-
sentation of the numbers 1, 2, 3, 4, and 5 and were required to
press a microswitch on the appearance of the number 5. In the
CPT-AX, participants were required to respond on the unpre-
dictable appearance of an “X” that had been preceded by an
“A.” In all tasks, the numbers and letters remained on the
screen for 2.0 seconds and were followed by a blank screen for
1.5 seconds. The ratio of targets to nontargets was 1:4, and
the task duration was 280 seconds. For all tasks, a correct
response to a target was deﬁned as one that occurred no less
than 100 ms and no more than 1.5 seconds after the
appearance of the target. Any responses outside the correct
time intervals were deﬁned as errors of commission, or false
alarms, while failure to respond in the correct interval was
deﬁned as an error of omission.
The cognitive tasks were presented on a computer monitor.
Each letter subtended a horizontal and vertical angle of
approximately 1.0 when viewed by subjects from a ﬁxed
distance of 1.3 m. The stimulus used to evoke the SSVEP was
a spatially diffuse 13-Hz sinusoidal ﬂicker subtending a hori-
zontal angle of 160 and a vertical angle of 90, which was
superimposed on the visual ﬁelds. This ﬂicker was present
throughout the task, and special goggles enabled subjects to
simultaneously view the cognitive task and the sinusoidal
ﬂicker.rg/journal
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The EEG was recorded from 64 scalp sites that included all
international 10-20 positions, with additional sites located
midway between 10-20 locations previously described (25,29).
The SSVEP is the event-related potential elicited by the 13-Hz
visual ﬂicker and is determined from the EEG Fourier co-
efﬁcients evaluated over 10 stimulus cycles at the stimulus
frequency of 13 Hz, thus yielding a temporal resolution of 0.77
second (25).
FC and SSVEP Event-Related Partial Coherence
Brain FC was measured using an event-related potential
methodology termed SSVEP event-related partial coherence
(SSVEP-ERPC). We have previously used SSVEP-ERPC to
examine changes in brain FC associated with cognitive tasks
(30) and more recently comparing ADHD and typically devel-
oping groups while performing the continuous performance
task (25). For more details on the SSVEP-ERPC methodology
and statistical considerations, the reader is referred to refer-
ence (25).
For each subject, the SSVEP-ERPC was calculated for all
2016 distinct pairs of electrodes averaged across all correct
responses in the reference task and CPT-AX before and after
MPH administration. Electrode pairs with high partial coher-
ence reﬂect a stable synchronization or phase difference of the
SSVEP between electrode pairs across trials and are thought
to reﬂect FC between the relevant regions, and thus we will
use SSVEP-ERPC and FC interchangeably. Details of the
SSVEP-ERPC methodology have been previously described
(25,29,30).
For both tasks, SSVEP-ERPC was determined for the 7.0-
second interval centered on the appearance of the number 5
in the reference task and the “X” in the CPT-AX. To examine
the relationship between the initial changes in FC associated
with the MPH dose and the 3-month improvement in hyper-
activity and inattention symptoms, we calculated the correla-
tion coefﬁcient between the changes in FC (deﬁned as DFC =
post MPH FC 2 pre MPH FC) and the 3 month SIS for each
point in time, separately for inattention (I-SIS) and hyperactivity
(H-SIS).
To explore temporal variation in the strength of the corre-
lation between the MPH-induced DFC and the corresponding
H-SIS and I-SIS, we determined the number of electrode pairs
where the magnitude of the correlation coefﬁcient r exceeds
.403, (jrj $ .403), a threshold value corresponding to p = .01 at
each point in time. Plots illustrating the temporal variation in
the number of DFC measures correlated with H-SIS and I-SIS
exceeding the threshold are termed correlation frequency
curves. A permutation test was then used to determine the






Inattention 20.2 (4.4) 11.3 (4.5)
Hyperactivity 16.2 (6.3) 9.3 (5.5)
MPH, methylphenidate.
Biological PsycSIS and DFC that exceeded the correlation coefﬁcient
threshold at a given point in time (26).
RESULTS
Behavioral Results
Premedication and postmedication mean RT (premedication
570 ms [SD 140], postmedication 571 ms [SD 142 ms]) did not
differ signiﬁcantly. However, pooling the MPH-mediated RT
changes obscures individual MPH-mediated RT changes. We
have previously reported that MPH-mediated changes in RT
were correlated with the MPH-mediated changes in FC such
that larger RT reductions are associated with larger FC
reductions. Readers are referred to our previous article for a
more detailed discussion on MPH-mediated RT changes in the
CPT-AX (24). While premedication and postmedication mean
number of errors of omission did not differ signiﬁcantly (pre-
medication errors of omission 1.30 [SD 1.9], postmedication
errors of omission 1.33 [SD 1.7]), there was a nonsigniﬁcant
tendency for a postmedication reduction in errors of com-
mission (premedication errors of commission 2.10 [SD 2.6],
postmedication errors of commission 1.73 [SD 1.9]).
Symptom Scores
The initial and 3-month parent symptom scores are listed in
Table 1. While both I-SIS and H-SIS improved over the
3-month period, these changes were not signiﬁcantly corre-
lated at the individual level (r38 = .287, p = .07).
Relationship Between First-Dose MPH–Induced
Changes in FC and 3-Month Symptom
Improvements
The correlation frequency curve for the number of electrode
pairs where the acute change in FC induced by the MPH dose,
DFC, is correlated with H-SIS is illustrated in Figure 1. H-SIS is
signiﬁcantly correlated with DFC at two points in time during
the CPT-AX, and in both cases, reductions in FC are associ-
ated with increases (improvements) in H-SIS. The ﬁrst point in
time occurs approximately 150 ms after the appearance of the
“A” where reductions in frontal-prefrontal FC were correlated
with increased H-SIS at a threshold level of jrj $ .403 corre-
sponding to p # .01 (Figure 1A) in 97 electrode pairs. The
second point in time occurs approximately 750 ms after the
appearance of the “X,” shortly after the mean reaction time,
where FC reductions at right temporofrontal-prefrontal and
frontal-prefrontal regions are correlated with hyperactivity
symptom improvements. In both cases, the permutation test
indicated that the null hypothesis (no correlation between the
number of electrode pairs identiﬁed and H-SIS) can be rejected
at the p = .03 level. Finally, at an r $ .403, we are observing amptom Scores Before and 3 Months After Starting MPH




t39 = 12.4, p , 10
25 0.43 (0.17)
t39 = 8.0, p , 10
25 0.39 (0.30)
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Figure 1. Correlation frequency curve for the
number of electrode pairs where methylphenidate-
induced changes in functional connectivity (DFC)
are correlated with hyperactivity symptom improve-
ment score (H-SIS), with jrj $ .403 corresponding to
p # .01. The red trace indicates the number of
electrode pairs where DFC is positively correlated
with H-SIS, while the blue trace illustrates the cor-
responding value where DFC is negatively correlated
with H-SIS. Overwhelmingly, we see a negative
correlation between DFC at frontal and prefrontal
sites and H-SIS indicating that long-term hyperac-
tivity symptom reductions were associated with a
methylphenidate-mediated reduction in FC. Permu-
tation tests indicate that the probability of observing
the illustrated number of correlations by chance
(the null hypothesis) is p , .01 for the ﬁrst peak (A)
and p , .01 for the second peak (B). Neg, negative;
Pos, positive.
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Figure 1. The extent to which 3-month H-SIS is predicted by a
frontal-prefrontal MPH-induced DFC at a point in time 150 ms
after the appearance of the “A” is illustrated in Figure 2.
I-SIS, similar to H-SIS, is also negatively correlated with
DFC in that reductions in inattention (or increases in I-SIS) are
associated with an MPH-induced reduction in FC (Figure 3).
While the correlations of DFC with H-SIS and I-SIS are both
negative, the time in the task trial where this relationship be-
comes signiﬁcant and the topography of the FC correlated with
I-SIS are different. I-SIS is maximally correlated with occipi-
toparietal DFC approximately 1000 ms after the appearance of
the “A.” A permutation test indicated that the null hypothesis
(no correlation between the number of electrode pairs identi-
ﬁed and I-SIS) can be rejected at the p = .01 level. Finally, the
extent to which 3-month I-SIS is predicted by an occipital-
parietal MPH-induced DFC at a point in time 1000 ms after682 Biological Psychiatry November 1, 2017; 82:679–686 www.sobp.othe appearance of the “A” is illustrated in Figure 4. The
Supplement provides an analysis of the ﬁndings based on the
difference in symptom score rather than the proportional dif-
ference used here.DISCUSSION
To the best of our knowledge, this is the ﬁrst study reporting a
relationship between ﬁrst-dose MPH–induced changes in brain
FC and long-term response of ADHD symptoms to stimulant
medication. It is notable that both inattention and hyperactivity
symptoms exhibited improvements after 3 months on MPH
and that both of these improvements were associated with
initial MPH–induced FC reductions. In broad terms, these
ﬁndings are consistent with the notion that MPH may achieve
its therapeutic effect by increasing DA and NE levels, which
suppress brain FC networks interfering with task performance,Figure 2. Scatterplot illustrating the initial
methylphenidate-induced change in functional con-
nectivity (DFC) between frontal-prefrontal electrodes
AF3–F4 (arrow) at the point in time illustrated in
Figure 1A vs. 3-month hyperactivity symptom
improvement score (H-SIS). The best-ﬁt linear rela-
tionship between H-SIS and DFC gives an indication
of the likely improvement in hyperactivity symptoms
based on the initial changes in AF3–F4 FC at the
point in time 150 ms after the appearance of the
“A” in correct AX continuous performance task
trials. v, versus.
rg/journal
Figure 3. Correlation frequency curve for the
number of electrode pairs where methylphenidate-
induced changes in functional connectivity (DFC)
are correlated with inattention symptom improve-
ment score, with jrj . .403 corresponding to p ,
.01. The red trace indicates the number of elec-
trode pairs where DFC is positively correlated with
inattention symptom improvement score, while the
blue trace illustrates the corresponding value
where DFC is negatively correlated with inattention
symptom improvement score. As in Figure 1,
methylphenidate-mediated reductions in parieto-
occipital FC were associated with long-term
improvements in inattention symptoms. A permu-
tation test indicated that the probability of
observing the illustrated number of correlations
illustrated in (A) by chance (the null hypothesis) is
p = .01. Neg, negative; Pos, positive.
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sections, we consider the relationship between the initial
MPH–induced changes in FC and each of the symptoms, hy-
peractivity and inattention, separately. We base this relation-
ship on the fact that the 3-month MPH–induced changes in
hyperactivity and inattention symptom scores are not signiﬁ-
cantly correlated as well as the fact that the timing and
topography of DFC correlated with long-term improvements in
hyperactivity symptoms differ from the timing and topography
of DFC correlated with the inattention symptom improvements.
Brain FC Correlates of Hyperactivity Symptom
Improvements
Of the two points in time during the CPT-AX trials where DFC
was correlated with increased H-SIS, the ﬁrst of the correlatedBiological PsycFC changes was located at frontal-prefrontal sites and
occurred immediately after the appearance of the warning “A”
(Figure 1A). We suggest this DFC could represent reduced
motor and supplementary motor activity during the appear-
ance of the “A” and could be associated with reduced impul-
sivity and a reduced tendency to commit an error of
commission by responding to the appearance of the “A.” This
is consistent with our observation of a nonsigniﬁcant decrease
in the number of errors of commission in the post-MPH con-
dition. The other point in time where DFC is correlated with
increased H-SIS occurs approximately 750 ms after the
appearance of the “X” and approximately 200 ms after the
mean response time. At this point in time, the topography of
DFC is predominantly bilateral frontal and right temporofrontal
(Figure 1B). The timing of this second peak of correlationFigure 4. Scatterplot illustrating the initial
methylphenidate-induced change in functional con-
nectivity (DFC) between occipital-parietal electrodes
CP3–PO3 (arrow) at the point in time illustrated in
Figure 3 vs. 3-month inattention symptom improve-
ment score (I-SIS). The best-ﬁt linear relationship
between I-SIS and DFC gives an indication of the
likely improvement in hyperactivity symptoms based
on the initial changes in CP3–PO3 FC at the point in
time 1000 ms after the appearance of the “A” in
correct AX continuous performance task trials.
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termination of the motor response.
To the extent that our FC measures may give some indi-
cation of regional brain activity, our ﬁndings are consistent with
a number of studies reporting increased regional brain activity
at motor execution and planning areas in ADHD (13). The
ﬁndings are also consistent with transcranial magnetic stimu-
lation studies of ADHD that indicate reduced gamma-
aminobutyric acid–mediated synaptic inhibition in the motor
cortex (31). However, to interpret our hyperactivity ﬁndings in
the context of ADHD as a disorder of FC, we draw on func-
tional magnetic resonance imaging (fMRI) ﬁndings concerning
the relationship between impulsivity and brain FC. Some of
these fMRI studies indicated that the normal negative corre-
lation between the DMN and regions associated with motor
planning and execution are altered in individuals with high
impulsivity. The normal negative correlation is either reduced
or replaced with a positive correlation between the DMN and
the motor planning and execution regions, such as the left and
right dorsolateral premotor cortex (32,33). In other words, high
impulsivity was associated with a positive right dorsolateral
premotor cortex–DMN correlation, suggesting that impulsivity
could arise from the DMN, driving motor planning and
execution areas. We consider this ﬁnding useful, as it offers an
interpretive framework for understanding ADHD hyperactivity
symptomatology in the context of DMN connectivity abnor-
malities. The role of the DMN in ADHD symptomatology is
most frequently discussed in the context of attentional deﬁcits,
where DMN intrusions are thought to contribute to the atten-
tional deﬁcits in ADHD. The above-mentioned studies offer a
parsimonious interpretation of why DMN functional abnor-
malities may contribute to both attention deﬁcits and hyper-
activity and why the frontal-prefrontal FC changes correlated
with hyperactivity symptom improvement that we have
observed may be driven (directly or indirectly) by abnormal
DMN activity. In other words, our observations of MPH-
induced reduction in frontal-prefrontal FC being correlated
with improved H-SIS is consistent with the possibility that
frontal-prefrontal FC reduction is in part mediated by MPH
reduction of DMN activity and hence a reduction of DMN
activation of the motor planning and motor execution regions
previously described (32,33).Brain FC Correlates of Inattention Symptom
Improvements
While improvements in both hyperactivity and inattention
symptoms are associated with reductions in FC during speciﬁc
intervals in the CPT-AX, the similarity ends there. Not only did
the correlation between DFC and I-SIS occur at one point in
time, but more importantly, it exhibited a different topography
in that the DFC associated with inattention symptom im-
provements was restricted to occipitoparietal sites. The fact
that the peak correlation between DFC and I-SIS occurs only
once 1.0 second after the appearance of the alerting stimulus
“A” suggests that the improvements are associated with
enhanced cue processing. Our ﬁndings point to occipitopar-
ietal involvement in ADHD inattention symptomatology and
indicate that MPH reductions in parieto-occipital FC during the
cue “A” are associated with long-term improvements in684 Biological Psychiatry November 1, 2017; 82:679–686 www.sobp.oinattention symptom score. The fact that improvement in
inattention symptoms is marked by reduced occipitoparietal
FC is also consistent with the notion that inattention is asso-
ciated with an inability to suppress attention to irrelevant
stimuli (34).
While the occipital cortex is not normally considered rele-
vant to ADHD (13), a number of EEG and fMRI studies have
reported occipital abnormalities in ADHD. For example, Vance
et al. (35) reported reduced occipitoparietal activity in a cohort
of boys diagnosed with ADHD combined subtype while they
performed a mental rotation task. Similarly, occipital FC dif-
ferences between ADHD inattentive subtype and ADHD com-
bined subtype were reported in an fMRI study (36). Our
observation that occipitoparietal DFC correlated with I-SIS
during the “A” cue is also consistent with the ﬁndings of an
ADHD CPT-AX event-related potential study that reported that
differences between ADHD and typically developing groups
during the alerting “A” were restricted to posterior electrodes
(37), ﬁndings that were subsequently conﬁrmed (38).
Studies using fMRI that reported increased occipital activity
in ADHD have been interpreted as an indication of ADHD-
related compensatory activity in a cognitive task (39). While
our observation of the relationship between MPH-mediated
occipitoparietal FC reduction predicting 3-month inattention
symptom improvements is consistent with the compensatory
activity hypothesis, we suggest our ﬁndings also allow an
alternative hypothesis. Speciﬁcally, our ﬁndings are consistent
with the hypothesis that the ADHD inattention symptoms may
be in part a consequence of DMN positively activating or
driving the visual cortex. In this case, the increased occipital
activity observed in ADHD may be due to abnormal DMN
activation of the visual cortex rather than compensatory acti-
vation of the visual cortex. While task positive networks such
as the visual network are normally negatively correlated with
DMN activity, this negative correlation is reduced in ADHD,
and a positive correlation is frequently observed (40). Such a
positive correlation between DMN and occipital activity would
be consistent with the possibility of DMN driving the visual
network, thereby giving rise to symptoms of inattention and
increased distractibility. Our observations of MPH-induced
reduction in occipitoparietal FC being correlated with
improved I-SIS is consistent with the possibility that the
occipitoparietal FC reduction is in part mediated by MPH
reduction of DMN activity and hence a reduction of DMN
activation of the visual networks.
On a more general note, our ﬁndings suggest that im-
provements in inattention and hyperactivity symptoms may be
in part mediated by distinct cortical networks, and this is
consistent with some reports suggesting that the ADHD inat-
tentive and ADHD combined subtypes may possibly constitute
distinct disorders (41). Hyperactivity symptom improvements
may be mediated predominantly by reductions in FC in frontal
and motor supplementary cortex networks, whereas inatten-
tion symptom improvements may be associated with posterior
attentional network system FC reductions. While MPH appears
to improve both hyperactivity and inattention symptoms, the
distinct anteroposterior distinction in the topography of DFC
suggests that both DA and NE may play distinct roles in
symptomatic improvement. Given the predominantly frontal
bias of DA projections originating in the ventral tegmental arearg/journal
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nating in the locus coeruleus, our ﬁndings are consistent with
the possibility that MPH-mediated improvements in hyperac-
tivity symptoms are mediated by DA changes, whereas the
improvements in inattention symptoms occur as a result of
MPH-induced increases in NE (4). Notwithstanding the
differing roles of these catecholamines in mediating improve-
ments in inattention and hyperactivity symptoms, our ﬁndings
are consistent with the possibility that the DMN is likely to play
a role in both sets of symptoms.
Conclusions
While we believe these ﬁndings may be of interest, a number of
caveats apply. First, no aspect of the diagnosis or treatment of
participants was at the discretion of the investigators. As such,
we have limited information on the extent to which patients
adhered to the prescribed MPH intake level or the changes in
MPH dosage recommended by individual clinicians. Second,
all participants were MPH naïve, and it is possible that par-
ticipants who had been previously prescribed MPH may
respond differently. In addition, there is a need to determine
the replicability of our ﬁndings in a larger patient group.
Furthermore, any larger replication study should make use of
both teacher and parent ratings. Finally, in considering a
replication study, it is important to note that the ﬁndings
depend very much on the methodology used to determine FC.
Our method using the 13-Hz SSVEP to determine FC would be
biased to cortical communication components mediated by
oscillations around 13 Hz. This is important, as top-down or
feedback cortical communication is thought to be mediated by
synchronous oscillations in the 10- to 20-Hz range (26,42), and
thus our ﬁndings are preferentially sensitive to top-down
processes.
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